These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Ambrose CS; Wu X; Jones T; Mallory RM Vaccine; 2012 Nov; 30(48):6794-801. PubMed ID: 23000125 [TBL] [Abstract][Full Text] [Related]
25. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Lum LC; Borja-Tabora CF; Breiman RF; Vesikari T; Sablan BP; Chay OM; Tantracheewathorn T; Schmitt HJ; Lau YL; Bowonkiratikachorn P; Tam JS; Lee BW; Tan KK; Pejcz J; Cha S; Gutierrez-Brito M; Kaltenis P; Vertruyen A; Czajka H; Bojarskas J; Brooks WA; Cheng SM; Rappaport R; Baker S; Gruber WC; Forrest BD Vaccine; 2010 Feb; 28(6):1566-74. PubMed ID: 20003918 [TBL] [Abstract][Full Text] [Related]
26. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years. Tennis P; Toback SL; Andrews E; McQuay LJ; Ambrose CS Vaccine; 2011 Jul; 29(31):4947-52. PubMed ID: 21596087 [TBL] [Abstract][Full Text] [Related]
27. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children. Curtis D; Ning MF; Armon C; Li S; Weinberg A Vaccine; 2015 Sep; 33(38):4790-7. PubMed ID: 26241950 [TBL] [Abstract][Full Text] [Related]
28. The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults. Ambrose CS; Wu X Vaccine; 2013 Jan; 31(6):857-60. PubMed ID: 23261050 [TBL] [Abstract][Full Text] [Related]
29. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Levin MJ; Song LY; Fenton T; Nachman S; Patterson J; Walker R; Kemble G; Allende M; Hultquist M; Yi T; Nowak B; Weinberg A Vaccine; 2008 Aug; 26(33):4210-7. PubMed ID: 18597900 [TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial. Wu J; Liu SZ; Dong SS; Dong XP; Zhang WL; Lu M; Li CG; Zhou JC; Fang HH; Liu Y; Liu LY; Qiu YZ; Gao Q; Zhang XM; Chen JT; Zhong X; Yin WD; Feng ZJ Vaccine; 2010 Aug; 28(38):6221-7. PubMed ID: 20638454 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents. Ogimi C; Tanaka R; Saitoh A; Oh-Ishi T Pediatr Infect Dis J; 2011 Mar; 30(3):208-11. PubMed ID: 20861757 [TBL] [Abstract][Full Text] [Related]
32. Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women. Brady RC; Jackson LA; Frey SE; Shane AL; Walter EB; Swamy GK; Schlaudecker EP; Szefer E; Wolff M; McNeal MM; Bernstein DI; Steinhoff MC Vaccine; 2018 Jul; 36(31):4663-4671. PubMed ID: 29961606 [TBL] [Abstract][Full Text] [Related]
33. Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects. Block SL; Reisinger KS; Hultquist M; Walker RE; Antimicrob Agents Chemother; 2007 Nov; 51(11):4001-8. PubMed ID: 17724151 [TBL] [Abstract][Full Text] [Related]
34. Benefits and risks of live attenuated influenza vaccine in young children. Oster G; Weycker D; Edelsberg J; Nichol KL; Klein JO; Belshe RB Am J Manag Care; 2010 Sep; 16(9):e235-44. PubMed ID: 21250400 [TBL] [Abstract][Full Text] [Related]
36. Criteria in the evaluation of live intranasal influenza virus vaccines. Zygraich N Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962 [TBL] [Abstract][Full Text] [Related]
37. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers. Freestone DS Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971 [TBL] [Abstract][Full Text] [Related]
38. Optimizing protection against influenza in children eligible for the vaccine for children program. Hull HF; O'Connor H Pediatr Infect Dis J; 2010 Oct; 29(10):910-4. PubMed ID: 20431426 [TBL] [Abstract][Full Text] [Related]
39. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains. Lee MS; Yang CF J Infect Dis; 2003 Nov; 188(9):1362-6. PubMed ID: 14593595 [TBL] [Abstract][Full Text] [Related]
40. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]